Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: Implications for HIV-1 vaccine efficacy trials

被引:0
|
作者
Baeten, JM
Richardson, BA
Martin, HL
Nyange, PM
Lavreys, L
Ngugi, EN
Mandaliya, K
Ndinya-Achola, JO
Bwayo, JJ
Kreiss, JK
机构
[1] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98104 USA
[3] Univ Washington, Dept Med, Seattle, WA 98104 USA
[4] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya
[5] Univ Nairobi, Dept Community Hlth, Nairobi, Kenya
[6] Coastal Prov Gen Hosp, Mombasa, Kenya
关键词
HIV-1; incidence; vaccine; prostitutes; sexual behavior; STD; Africa;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Accurate predictions of HIV-1 incidence in potential study populations are essential for designing HIV-1 vaccine efficacy trials. Little information is available on the estimated incidence of HIV-I in such populations, especially information on incidence over time and incidence while participating in risk-reduction programs. Objectives: To examine time trends in HIV-1 incidence in a vaccine preparedness cohort. Design: Prospective cohort study of female prostitutes in Mombasa, Kenya. Methods: HIV-1 incidence was determined using open and closed cohort designs. Generalized estimating equations were used to model HIV-1 and sexually transmitted disease (STD) incidence and sexual risk behaviors over time. Results: When analyzed as a closed cohort, HIV-1 incidence declined 10-fold during 3 years of follow-up (from 17.4 to 1.7 cases/100 person-years; p <.001). More than 50% of the cases of HIV-1 occurred during the first 6 months after enrollment, and 73% during the first 12 months. When analyzed as an open cohort, HIV-1 incidence density fell during the first 4 calendar years, influenced by accumulation of lower risk participants and variations in study recruitment. Significant declines occurred in both STD incidence and high-risk sexual behaviors during follow-up. Conclusions: This study documents a dramatic decline in the risk of HIV-1 infection while participating in a prospective cohort, with most seroconversions occurring within 1 year of enrollment. Variations in HIV-1 incidence within high-risk populations should be anticipated during the design of vaccine trials.
引用
收藏
页码:458 / 464
页数:7
相关论文
共 50 条
  • [21] The HIV-1 vaccine race
    Ho, DD
    Huang, YX
    CELL, 2002, 110 (02) : 135 - 138
  • [22] HIV-1 Superinfection and its Implications for Vaccine Design
    Chohan, Bhavna H.
    Piantadosi, Anne
    Overbaugh, Julie
    CURRENT HIV RESEARCH, 2010, 8 (08) : 596 - 601
  • [23] Neutralization of HIV-1 subtypes: Implications for vaccine formulations
    Smith, TL
    van Rensburg, EJ
    Engelbrecht, S
    JOURNAL OF MEDICAL VIROLOGY, 1998, 56 (03) : 264 - 268
  • [24] HIV-1 INCIDENCE RATES IN HIGH-RISK POPULATIONS - IMPORTANCE IN VACCINE TRIALS
    NELSON, KE
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 746 - 746
  • [25] Declining HIV-1 prevalence and incidence among Police Officers – a potential cohort for HIV vaccine trials, in Dar es Salaam, Tanzania
    Patricia J Munseri
    Muhammad Bakari
    Mohamed Janabi
    Eric Aris
    Said Aboud
    Bo Hejdeman
    Eric Sandstrom
    BMC Public Health, 13
  • [26] Declining HIV-1 prevalence and incidence among Police Officers - a potential cohort for HIV vaccine trials, in Dar es Salaam, Tanzania
    Munseri, Patricia J.
    Bakari, Muhammad
    Janabi, Mohamed
    Aris, Eric
    Aboud, Said
    Hejdeman, Bo
    Sandstrom, Eric
    BMC PUBLIC HEALTH, 2013, 13
  • [27] Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: Relevance to HIV-1 vaccine trials in Uganda
    Cao, HY
    Mani, I
    Vincent, R
    Mugerwa, R
    Mugyenyi, P
    Kanki, P
    Ellner, J
    Walker, BD
    JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05): : 1350 - 1356
  • [28] HIV-1 subtypes in Nairobi, Kenya
    Belda, FJ
    Mwchari, C
    Hawken, M
    Barlow, KL
    Clewley, JP
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 16 (01): : 63 - 64
  • [29] Reducing HIV-1 in Kenya and Tanzania
    Moses, S
    Plummer, FA
    Nagelkerke, NJ
    LANCET, 2000, 356 (9241): : 1602 - 1602
  • [30] Determinants of HIV-1 Late Presentation in a Cohort of Portuguese HIV-1 Patients
    Miranda, Ana Claudia
    Miranda, Mafalda
    Pingarilho, Marta
    Pimentel, Victor
    Torres, Joao
    Peres, Susana
    Baptista Alberto, Teresa
    Gomes, Perpetua
    Abecasis, Ana
    Mansinho, Kamal
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (11) : 846 - 851